Fastest-growing source for untaught money moves, uncensored trade signals, and income streams they hoped you’d never find. Follow before it spreads.
Joined August 2010
- Tweets3.2K
- Following335
- Followers129
- Likes923
Pinned Tweet
Need stocks to watch right now? FINVIZ lets you screen thousands of stocks by your exact criteria in seconds—so you can get to potential setups faster instead of scrolling through tickers. finviz.com/?affilId=21020903… #StockScreener #MomentumTrading #SwingTrading #friday #afterhours
fastmoneysource retweeted
I decided to put Tilt to the test under some less-than-ideal circumstances. With a 458 credit score and 7 installment loans, I wasn’t expecting much. But what happened after I applied caught me completely off guard. I documented the experience step by step. 👇
I decided to put Tilt to the test under some less-than-ideal circumstances. With a 458 credit score and 7 installment loans, I wasn’t expecting much. But what happened after I applied caught me completely off guard. I documented the experience step by step. 👇
That’s my actual Tilt experience. I received a $250 offer and the money was made available to me within about 5 minutes. If you want to check Tilt for yourself, here’s the link I used: tilt.com/r/LTZCGD Offers, eligibility and timing can vary. #TiltReview #CashAdvance
The transfer was straightforward on my end. I was able to move the money toward my bank account without having to jump through a bunch of hoops. That made the experience even more interesting to me.
The next thing I tested was the transfer. I wanted to see whether getting the offer was the easy part—or whether actually moving the money to my bank would be just as straightforward.
That was the part that impressed me most. I wasn’t expecting the process to move that quickly, especially after seeing the offer. So I decided to test the rest of the process and see how easy it was to actually move the money where I needed it.
And then came the part I really wanted to know: How fast would I actually get access to the money? For me, it was within about 5 minutes.
Then I saw the offer: $250. That alone caught my attention. But the part that really surprised me came next…
Most traders don’t need more stock ideas. They need a faster way to eliminate the stocks that don’t fit. FINVIZ lets you screen thousands of stocks using price, volume, relative volume, performance and technical criteria, save your screens, track new matches and move qualifying stocks into Advanced Charts. Build Monday’s watchlist from the stocks that actually match your criteria. Try FINVIZ Elite free for 7 days: finviz.com/?affilId=21020903… #DayTrading #StockTrading #StocksToWatch
$HII HII Hosts National Commission on the Future of The Navy at Ingalls Shipbuilding (2026-09-25) seekingalpha.com/pr/20664689…
$CGC Canopy Growth Announces Adjournment of 2026 Annual General and Special Meeting Due to Lack of Quorum (2026-09-25) seekingalpha.com/pr/20664721…
$HHH Reminder: HHH 2026 Annual Shareholder Meeting Set for September 30 (2026-09-25) seekingalpha.com/pr/20664788…
$HAFN HAFNIA LIMITED: Public Filing of Prospectus Supplement in Connection with the Offering (2026-09-25) seekingalpha.com/pr/20664804…
What if your stock screener could do the searching for you? Set the criteria you actually trade—price, volume, relative volume, performance, technical signals and more—and FINVIZ narrows thousands of stocks to the names that match. Build Monday’s watchlist without opening ticker after ticker. FINVIZ Elite adds real-time premarket/after-hours data, saved screens, alerts and Advanced Charts. Try Elite free for 7 days: finviz.com/?affilId=21020903… #StockScreener #StockScanner #TradingTools
$VRME VerifyMe Announces Reverse Stock Split of the Company’s Common Stock (2026-09-25) seekingalpha.com/pr/20664379…
$BMY Bristol Myers Squibb Announces First Presentation of Results for ZENBEXUS™ (iberdomide) in Combination with Daratumumab from Phase 3 EXCALIBER-RRMM Trial in Relapsed or Refractory Multiple Myeloma (2026-09-25) seekingalpha.com/pr/20664399…
$SLS SELLAS Life Sciences Presents Preclinical Data Demonstrating SLS009 Activity in Pancreatic Cancer Models at the 2026 AACR Conference on Pancreatic Cancer (2026-09-25) seekingalpha.com/pr/20664673…
Stop scanning blindly. FINVIZ adds Matrix, Similar Charts & automatic candlestick detection—plus real-time data, alerts & advanced screens. Try Elite FREE for 7 days: finviz.com/?affilId=21020903… #GapTrading #MomentumBreakouts
$IPEX GOWell Technology Limited and Inflection Point Acquisition Corp. V Announce Closing of Business Combination (2026-09-25) seekingalpha.com/pr/20664687…
$EQPT EquipmentShare Responds to Inaccurate Short Report (2026-09-25) seekingalpha.com/pr/20664758…